Paramedic Drug Profiles Flashcards
Drug Profile for Epinephrine (Group 3A)
What is the drug’s class?
- Sympathomimetic
Drug Profile for Epinephrine (Group 3A)
What is the drug’s mechanism of action?
- Alpha 1 - Increase systemic vascular resistance (bronchial, cutaneous, renal, and visceral arterial constriction)
- Beta 1 - postiive inotropic, chronotropic and dromotropic actions
- Beta 2 - bronchial smooth muscle relaxation and mild dilation of skeletal vasculature
- Increased myocardial workload and oxygen demand
- Histamine blocker
Drug Profile for Epinephrine (Group 3A)
What are the indications to use this medication?
- Cardiac arrest (V-fib, PVT, asystole, PEA)
- Severe bronchospasm (Asthma, bronchiolitis)
- Hypotension (refractory to any other therapy)
- Bradycardia
- Aaphylaxis
- Croup
Drug Profile for Epinephrine (Group 3A)
What is the drug’s adult dose and route?
Pulseless arrest:
- 1 mg (10 mL of 1:10,000) IV/IO, repeat every 3-5 min. (no max dose)
Hypoperfusion, symptomatic bradycardia or R.O.S.C. (to maintain SBP > 90 or MAP > 65 mmHg)
- 10 - 20 mcg (1 - 2 mL) IV/IO push every 2 min. (1 mL Epi 1:10,000 in 9 mL NS = 10 mcg/mL)
- 2 - 10 mcg/min IV/IO (2 mL of 1:1,000 added to 250 mL D5W/NS gives 8 mcg/mL)
Anaphylaxis/Asthma:
- 0.3 - 0.5 mg (0.3 - 0.5 mL of 1:1,000) IM via lateral thigh or deltoid, may repeat every 5 - 15 min.
- 1 mg (10 mL of 1:10,000) IV/IO over 5 minutes
- 2 - 4 mcg/min IV/IO continuous infusion (2 mL of 1:1,000 added to 250 mL D5W/NS gives 8 mcg/mL)
Drug Profile for Epinephrine (Group 3A)
What is the drug’s onset of action?
- IV/IO: < 2 minutes
- IM: 3 - 10 minutes
Drug Profile for Epinephrine (Group 3A)
What is the drug’s peak effect?
- IV/IO: < 5 minutes
- IM: 20 minutes
Drug Profile for Epinephrine (Group 3A)
What is the drug’s duration of action?
- IV/IO: 5 - 10 minutes
- IM: 20 - 30 minutes
Drug Profile for Amiodarone (Group 3A)
What is the class of the drug?
- Antiarrhythmic Agent
Drug Profile for Amiodarone (Group 3A)
What is the drug’s mechanism of action?
- Potassium channel blocker slows ventricular automaticity.
- Sodium channel blocker slows membrane depolarization and impulse conduction
- Calcium channel blocker and beta-blocker: negative chronotropic activity in nodal tissue: rate reduction
- Prolongs refractory period
- Dilates coronary arteries due to calcium channel and alpha-adrenergic blocking action
Drug Profile for Amiodarone (Group 3A)
What is indications to use this medication?
- VF/PVT, polymorphic VT (Torsades) and wide-complex tachycardia with a pulse of uncertain origin
- Hemodynamically stable ventricular tachycardia when cardioversion unsuccessful
- Adjunct to cardioversion of DVT and PSVT
- Rate control in atrial fibrillation and flutter
Drug Profile for Amiodarone (Group 3A)
What is the drug’s adult dose and route?
VF/PVT:
- 300 mg IV/IO push over a minute, may repeat in 3-5 min. with 150 mg IV/IO slow push (if needed)
Wide-complex tachycardia, more than 5 PVCs in a minute, refractory A-fib or flutter, SVT:
- 150 mg in 100 mL D5 IV/IO over 10 min., may repeat in 10 min. (if needed)
Infusion after ROSC:
- 1 mg/min IV/IO drip over 6 hrs., then 0.5 mg/min over 18 hrs., (max dose 2.2 Gm/day)
Drug Profile for Amiodarone (Group 3A)
What is the drug’s onset of action?
- 1 - 2 min.
Drug Profile for Amiodarone (Group 3A)
What is the drug’s peak effect?
- 10 min.
Drug Profile for Amiodarone (Group 3A)
What is the drug’s duration of action?
- Varies
Drug Profile for Lidocaine, 2%
What is the class of this drug?
- Antiarrhythmic
- Anesthetic post-intraosseous insertion